Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inozyme Pharma

3.99
0.0000
Volume:543.11K
Turnover:2.16M
Market Cap:258.69M
PE:-2.37
High:3.99
Open:3.98
Low:3.98
Close:3.99
Loading ...
Aug 11, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jul 28, 2023

Major Issues Report

Form 8-K - Current report
Jul 26, 2023

Major Issues Report

Form 8-K - Current report
Jun 30, 2023

Correspondence

Form CORRESP - Correspondence
Jun 28, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 23, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 04, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 22, 2023

Major Issues Report

8-K - Current report
Mar 22, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 07, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2023

Major Issues Report

8-K - Current report